查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1953716

全球尼古丁口香糖市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Nicotine Gum Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 113 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计尼古丁口香糖市场将从 2025 年的 22 亿美元成长到 2034 年的 37.7 亿美元，2026 年至 2034 年的复合年增长率为 6.18%。

随着越来越多的人寻求有效的戒烟方法并控制尼古丁瘾，尼古丁口香糖市场正经历显着成长。尼古丁口香糖是一种尼古丁替代疗法（NRT），它能帮助吸烟者减少对尼古丁的依赖，同时减轻戒断症状和烟瘾。随着公共卫生措施和宣传宣传活动不断推动戒烟，预计对尼古丁口香糖的需求将持续成长。尤其是在各国政府和卫生组织持续推行旨在降低吸烟率和倡导健康生活方式的政策之际，这一趋势显得尤为重要。

此外，人们对健康和保健日益增长的兴趣也影响着尼古丁口香糖市场。随着消费者健康意识的增强，对能够帮助他们戒烟并促进整体健康的产品需求也日益增长。为了顺应这一趋势，製造商正在开发各种口味和配方的尼古丁口香糖，以满足不同消费者的偏好。随着越来越多的人寻求更具吸引力且有效的戒烟方法，这种多元化预计将推动市场成长。

此外，研发领域的进步正在改变尼古丁口香糖市场的格局。市场创新主要源自于新配方的研发，这些新配方能够提高尼古丁口香糖的功效并改善使用者体验。此外，行动应用程式和线上支援计画等数位健康技术的整合，为吸烟者提供了更多资源和工具，以帮助他们戒烟。因此，在公共卫生倡议、消费者偏好变化以及戒烟解决方案进步的推动下，尼古丁口香糖市场预计将迎来显着成长。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球尼古丁口香糖市集（按类型划分）

  • 市场分析、洞察与预测
  • 2mg
  • 4mg

5. 全球尼古丁口香糖市集依通路划分

  • 市场分析、洞察与预测
  • 超级市场和大卖场
  • 便利商店
  • 药局
  • 在线的

6. 全球尼古丁口香糖市集（按地区划分）

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商格局（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Johnson & Johnson
    • Novartis AG
    • ITC Limited
    • Cipla Health Limited
    • Perrigo Company Plc
    • Teva Canada
    • Philip Morris
    • British American Tobacco PLC
    • Revolymer
    • Fertin Pharma
简介目录
Product Code: VMR112112017

The Nicotine Gum Market size is expected to reach USD 3.77 Billion in 2034 from USD 2.20 Billion (2025) growing at a CAGR of 6.18% during 2026-2034.

The nicotine gum market is experiencing significant growth as more individuals seek effective solutions to quit smoking and manage nicotine cravings. Nicotine gum, a form of nicotine replacement therapy (NRT), provides smokers with a way to reduce withdrawal symptoms and cravings while gradually decreasing their dependence on nicotine. As public health initiatives and awareness campaigns promote smoking cessation, the demand for nicotine gum is expected to rise. This trend is particularly relevant as governments and health organizations continue to implement policies aimed at reducing smoking rates and promoting healthier lifestyles.

Moreover, the increasing focus on health and wellness is influencing the nicotine gum market. As consumers become more health-conscious, there is a growing demand for products that support smoking cessation and promote overall well-being. Manufacturers are responding to this trend by developing nicotine gum with various flavors and formulations that cater to different consumer preferences. This diversification is expected to drive market growth as more individuals seek appealing and effective options for quitting smoking.

Additionally, advancements in research and development are transforming the nicotine gum landscape. The development of new formulations that enhance the effectiveness of nicotine gum and improve user experience is driving innovation in the market. Furthermore, the integration of digital health technologies, such as mobile apps and online support programs, is providing smokers with additional resources and tools to aid in their cessation efforts. The nicotine gum market is thus positioned for significant growth, driven by public health initiatives, changing consumer preferences, and advancements in smoking cessation solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • 2mg
  • 4mg

By Distribution Channel

  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Pharmacies
  • Online

COMPANIES PROFILED

  • Johnson Johnson, Novartis AG, ITC Limited, Cipla Health Limited, Perrigo Company Plc, Teva Canada, Philip Morris, British American Tobacco PLC, Revolymer, Fertin Pharma

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NICOTINE GUM MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. 2mg Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. 4mg Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NICOTINE GUM MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Distribution Channel
  • 5.2. Supermarkets/Hypermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Convenience Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NICOTINE GUM MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By Distribution Channel
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By Distribution Channel
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By Distribution Channel
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By Distribution Channel
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By Distribution Channel
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NICOTINE GUM INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Johnson & Johnson
    • 8.2.2 Novartis AG
    • 8.2.3 ITC Limited
    • 8.2.4 Cipla Health Limited
    • 8.2.5 Perrigo Company Plc
    • 8.2.6 Teva Canada
    • 8.2.7 Philip Morris
    • 8.2.8 British American Tobacco PLC
    • 8.2.9 Revolymer
    • 8.2.10 Fertin Pharma